Cosmo Pharmaceuticals NV
SIX:COPN

Watchlist Manager
Cosmo Pharmaceuticals NV Logo
Cosmo Pharmaceuticals NV
SIX:COPN
Watchlist
Price: 65 CHF Market Closed
Market Cap: 1B CHF
Have any thoughts about
Cosmo Pharmaceuticals NV?
Write Note

Cosmo Pharmaceuticals NV
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Cosmo Pharmaceuticals NV
Research & Development Peer Comparison

Comparables:
PRGO
JAZZ
AVDL
G
GHRS
OVB

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Cosmo Pharmaceuticals NV
SIX:COPN
Research & Development
-€21.3m
CAGR 3-Years
-16%
CAGR 5-Years
-9%
CAGR 10-Years
0%
Perrigo Company PLC
NYSE:PRGO
Research & Development
-$114m
CAGR 3-Years
3%
CAGR 5-Years
8%
CAGR 10-Years
3%
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
Research & Development
-$860.1m
CAGR 3-Years
-22%
CAGR 5-Years
-18%
CAGR 10-Years
-12%
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
Research & Development
-$12.3m
CAGR 3-Years
17%
CAGR 5-Years
19%
CAGR 10-Years
-5%
G
GH Research PLC
NASDAQ:GHRS
Research & Development
-$29.5m
CAGR 3-Years
-343%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Ovoca Bio PLC
LSE:OVB
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Cosmo Pharmaceuticals NV's Research & Development?
Research & Development
-21.3m EUR

Based on the financial report for Jun 30, 2024, Cosmo Pharmaceuticals NV's Research & Development amounts to -21.3m EUR.

What is Cosmo Pharmaceuticals NV's Research & Development growth rate?
Research & Development CAGR 10Y
0%

Over the last year, the Research & Development growth was -32%. The average annual Research & Development growth rates for Cosmo Pharmaceuticals NV have been -16% over the past three years , -9% over the past five years .

Back to Top